Chronic Pain

The Texas House has voted to add chronic pain and Crohn’s disease to the state’s list of medical cannabis qualifying conditions. The bill would also give patients access to new products.

Illinois health officials have announced four new additions to the list of qualifying conditions for the state’s medical cannabis program, including endometriosis, ovarian cysts, uterine fibroids, and female orgasmic disorder.

Nearly one-third (32%) of medical cannabis patients cite chronic pain as their primary condition for medical cannabis use, with anxiety the second most common (26.8%) followed by insomnia (18.5%).

A recent study found that terpenes could be an effective and side-effect-free treatment for chemotherapy-induced neuropathic pain.

Sen. John Tester (D-MT), chairman of the Senate Veterans Affairs Committee, said that a proposal to research medical cannabis use by veterans may be dead following its rejection in the Senate last week.

The Texas House voted 121-23 in favor of a measure to increase allowable THC levels in the state’s medical cannabis program and add chronic pain to the program’s qualifying conditions list.

The Texas House Public Health Committee has advanced a medical cannabis proposal that would remove the state’s 1% THC cap, establish a 10 mg volumetric dose for the program, and open the program up to patients experiencing chronic pain.

The U.S. Senate Committee on Veterans’ Affairs advanced a bill this week mandating investigations into the effectiveness of medical cannabis as a treatment for PTSD and chronic pain.

Researchers at Australia’s University of Sydney have launched the world’s first-ever study investigating the efficacy of CBD treatments for spinal cord injury-induced chronic pain.

Three out of 10 adults with chronic pain in states with legal medical cannabis access use cannabis products to manage their pain, according to a recent study.

The number of registered medical cannabis patients in the U.S. has quadrupled from 2016 to 2020 and the current total is just over 2.97 million patients, according to a recent study.

The Kentucky Senate will not vote on the state’s House-approved medical cannabis legislation because, according to Senate Majority Leader Damon Thayer (R), there are “not enough votes” to pass the bill.

Kentucky’s GOP-controlled House of Representatives voted 59-64 to pass a bill giving patients with certain severe illnesses access to a state medical cannabis program.

The Kentucky House Judiciary Committee passed a medical cannabis bill sponsored and supported by the state’s Republican lawmakers.

The NFL is donating $1 million to researchers to study the effects of cannabinoids on pain management in elite athletes.

Researchers at the University of Mississippi have been awarded $1.37 million to study if cannabis can help manage HIV-related pain in patients.

The Texas House approved expansions to the state’s medical cannabis program that would raise the THC limit from 0.5% to 5% and legalize access for patients with chronic pain, PTSD, and cancer.

A recently published German study showed that cannabis could be a promising treatment for reducing pain and muscle cramps in Parkinson’s patients.

A recent survey of 525 chronic pain patients found that 40.4% of respondents had replaced their opioid-based medications with medical cannabis.

The University of Pittsburgh has announced a 10-year research program with medical cannabis company Parallel (formerly Surterra Wellness).

More and more, CBD consumers tout the compound’s effectiveness at alleviating the symptoms of chronic pain. Let’s dive into the relationship between CBD and chronic pain, and how one might use CBD products to help reduce pain symptoms.

Minnesota health officials have approved chronic pain and a degenerative eye condition as new qualifying conditions for the state’s medical cannabis program.

Connecticut health officials have recommended adding chronic pain and Ehlers-Danlos syndrome as qualifying conditions for the state’s medical cannabis program.